Expanding horizons for the targeted management of EGFR-mutant NSCLC

Learning objective:         

After watching this broadcast, participants should be able to:

• Reflect on recent developments in the molecular diagnosis of EGFR-mutant NSCLC
• Describe updates in the management of advanced EGFR-mutant NSCLC
• Evaluate the use of novel emerging therapeutic options for EGFR exon 20 insertion mutations and their implementation into clinical practice

Faculty:

• Martin Reck (Germany)
• Umberto Malapelle (Italy)
• Maximilian Hochmair (Austria)
• Sabine Merkelbach-Bruse (Germany)
• Jordi Remon (Spain)